ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Contemporary Management of Ischemic Mitral Regurgitation at Coronary Artery Bypass Grafting

Friday, January 27, 2023

Submitted by

Cameron Lind

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2022.08.046

Author(s)

Michael J. Pienta, MD, MS, Patty Theurer, MSN, Chang He, MS, Melissa Clark, MSN,Jonathan Haft, MD, Steven F. Bolling, MD, Charles Willekes, MD, Hassan Nemeh, MD,Richard L. Prager, MD, Matthew A. Romano, MD, and Gorav Ailawadi, MD, MBA, on behalf ofthe Michigan Society of Thoracic and Cardiovascular Surgery Quality Collaborative

Since guidelines for treating ischemic mitral regurgitation (IMR) in patients undergoing coronary artery bypass grafting (CABG) have changed over time, this study aimed to assess the real-world impact of that change. Researchers found that, although the rate of valve replacement for severe IMR did not change, patients with moderate IMR were less likely to undergo replacement.